REVIEW ARTICLE |
|
Year : 2016 | Volume
: 64
| Issue : 5 | Page : 332-336 |
|
Genetic perspective of retinoblastoma: From present to future
Madhavan Jagadeesan1, Vikas Khetan2, Ashwin Mallipatna3
1 Department of Genetics and Molecular Biology, Vasan Medical Research Trust, Chennai, Tamil Nadu; Dual Helix Genetic Diagnostics Private Limited, Chennai, Tamil Nadu, India 2 Sri Bhagavan Mahavir Vitreo-Retinal Services, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India 3 Narayana Nethralaya, Bengaluru, India
Correspondence Address:
Dr. Madhavan Jagadeesan 120A, Bazaar Street, Saidapet, Chennai - 600 015, Tamil Nadu India
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/0301-4738.185585
|
|
Retinoblastoma (RB) is the most common malignant intraocular tumor in children. In the last decade, basic research has led to a better understanding of events after two hits in RB susceptibility gene (RB1), molecular mechanism of tumor growth, the cell of origin of RB, etc. This would pave way to identify biomarkers and molecular targeted therapy for better treatment option in the future. Furthermore, improvement in molecular techniques has led to enhanced diagnostic methods for early diagnosis, genetic counseling, and prevention of the disease. This review will help to understand the essence of basic research work conducted in recent times and its implication in the management of RB in the future. |
|
|
|
[FULL TEXT] [PDF]* |
|
|
|